GO
Loading...

Lightning Round: Sanofi, InterLinks, Ford Motor and More

CA Technologies : This application software company’s stock has no momentum, Cramer said. Go with Oracle instead.

Amarin : Although this Dublin-based drug manufacturer has no earnings or revenue to speak of, Cramer will bless this stock as a speculative buy.

McDermott International : Don’t buy this stock, Cramer said. He didn’t like that the heavy construction company recently reported a disappointing quarter.

Ford Motor : The automaker has considerable exposure to Europe and faces increasing commodity costs, making it hard for its stock to go higher any time soon. Nonetheless, Cramer wouldn’t mind owning F shares. He just doesn’t expect any upside in the near-term.

InterLinks : “What a disaster,” Cramer said of this technology company, which recently reported disappointing quarterly results. “Don’t buy.”

Sanofi : Cramer is a buyer of this drug manufacturer’s stock.










When this story was published, Cramer’s charitable trust owned Oracle and Sanofi.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
AMRN
---
CA
---
F
---
IL
---
MDR
---
ORCL
---
SNI
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.